Elliot Ehrich
Impact in
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects
- Treatment of Major Depression
- Biological Psychiatry top 5%
Papers in
- Pharmacology 17
- Inflammatory mediators and NSAID effects 10
- Treatment of Major Depression 6
-
- Pharmacological Receptor Mechanisms and Effects 3
- Co-authors
- Bernard L. Silverman (15 shared papers)James A. Bolognese (6 shared papers)Mark M. Davis (3 shared papers)Beth C. Seidenberg (4 shared papers)Jeffrey L. Jorgensen (2 shared papers)Philip A. Reay (1 shared paper)Ryan Z. Turncliff (9 shared papers)David J. Watson (1 shared paper)
- Journals
- Alcoholism Clinical and Experimental Research (3 papers)The Journal of Clinical Pharmacology (3 papers)Clinical Therapeutics (3 papers)American Journal of Psychiatry (2 papers)The Journal of Clinical Psychiatry (2 papers)
- Partner nations
- United StatesIrelandCanada
In The Last Decade
Elliot Ehrich
48 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 132
- Pharmacology 1.4k
- Biological Psychiatry 118
- Biochemistry 219
- Immunology 611
- Psychiatry and Mental health 364
Countries citing papers authored by Elliot Ehrich
This map shows the geographic impact of Elliot Ehrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elliot Ehrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elliot Ehrich more than expected).
Fields of papers citing papers by Elliot Ehrich
This network shows the impact of papers produced by Elliot Ehrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elliot Ehrich. The network helps show where Elliot Ehrich may publish in the future.
Co-authors
The 25 scholars most cited alongside Elliot Ehrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 462 | |
| 2 | Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. | 2000 | 374 |
| 3 | 1994 | 344 | |
| 4 | 1999 | 265 | |
| 5 | 1992 | 258 | |
| 6 | 1996 | 241 | |
| 7 | 2000 | 224 | |
| 8 | 1999 | 170 | |
| 9 | 2018 | 139 | |
| 10 | 2016 | 138 | |
| 11 | Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group. | 1999 | 132 |
| 12 | 2014 | 132 | |
| 13 | 2003 | 116 | |
| 14 | 1999 | 110 | |
| 15 | 2015 | 100 | |
| 16 | 2006 | 94 | |
| 17 | 1993 | 85 | |
| 18 | 2000 | 78 | |
| 19 | 2019 | 67 | |
| 20 | 2004 | 62 |
About Elliot Ehrich
Elliot Ehrich is a scholar working on Pharmacology, Molecular Biology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Epidemiology, having authored 49 papers that have together received 4.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Treatment of Major Depression (6 papers), Schizophrenia research and treatment (5 papers), T-cell and B-cell Immunology (3 papers), Substance Abuse Treatment and Outcomes (3 papers), Immunotherapy and Immune Responses (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). The work is most often cited by research in Pharmacology (1.4k citations), Biological Psychiatry (118 citations), Biochemistry (219 citations), Immunology (611 citations) and Psychiatry and Mental health (364 citations). Elliot Ehrich has collaborated with scholars based in United States, Ireland and Canada. Frequent co-authors include Bernard L. Silverman, James A. Bolognese, Mark M. Davis, Beth C. Seidenberg, Jeffrey L. Jorgensen, Philip A. Reay, Ryan Z. Turncliff, David J. Watson, N. Bellamy and John W. Loewy. Their work appears in journals such as Alcoholism Clinical and Experimental Research, The Journal of Clinical Pharmacology, Clinical Therapeutics, American Journal of Psychiatry and The Journal of Clinical Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.